Bioneem Tec India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.03 M
- Revenue Growth -17.92%
- Profit Growth -37.11%
- Ebitda 30.41%
- Net Worth 45.35%
- Total Assets 43.48%
About Bioneem Tec India
Bioneem Tec India Private Limited (BTIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2013 and has a history of 11 years and seven months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹4.03 M.
Magendran Balachary and Menaga Magendran serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TN2013PTC091862
- Company No.
091862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Bioneem Tec India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Menaga Magendran  | Director | 26-Jun-2013 | Current |
| Magendran Balachary | Director | 26-Jun-2013 | Current |
Financial Performance of Bioneem Tec India.
Bioneem Tec India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.92% decrease. The company also saw a substantial fall in profitability, with a 37.11% decrease in profit. The company's net worth Soared by an impressive increase of 45.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioneem Tec India?
In 2022, Bioneem Tec India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Negha Green Lab LlpMagendran Balachary and Menaga Magendran are mutual person
Charges (Loans)
₹4.03 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2024 | Sidbi | ₹4.03 M | Open |
How Many Employees Work at Bioneem Tec India?
Unlock and access historical data on people associated with Bioneem Tec India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioneem Tec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioneem Tec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.